Media

Omnicom beats estimates in Q1, but sees slight dip in North America

Omnicom beats estimates in Q1, but sees slight dip in North America

Omnicom's healthcare revenue was up 2.7% in Q1

National Psoriasis Foundation partners with Remedy Health Media

National Psoriasis Foundation partners with Remedy Health Media

By

The two organizations will partner on content including personal stories and expert advice.

Global adspend growth to accelerate to 4.7% in 'stellar' 2018

Global adspend growth to accelerate to 4.7% in 'stellar' 2018

By

Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).

Back to the Future:  Print media thrives in point of care

Back to the Future: Print media thrives in point of care

By

Not only isn't print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it's thriving in a most unlikely environment: the point of care

What Facebook's news feed changes mean for brands and publishers

What Facebook's news feed changes mean for brands and publishers

By

Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.

MM&M's 5 most-read agency stories of 2017

MM&M's 5 most-read agency stories of 2017

By

The agency issue, people moves, and a series of restructures top the list.

Rejuvenan Global Health names Hudson Cutler communications AOR

Rejuvenan Global Health names Hudson Cutler communications AOR

By

The digital health startup was founded in 2015.

GroupM unveils upbeat global adspend forecast for 2018

GroupM unveils upbeat global adspend forecast for 2018

By

GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.

Five things for pharma marketers to know: Wednesday, November 22, 2017

Five things for pharma marketers to know: Wednesday, November 22, 2017

WebMD reportedly lays off 10% of workforce; Roche blocks Herceptin biosimilar with patent suit; insurers cover Collegium's Xtampza over Purdue's OxyContin

PRWeek and MM&M hire NBC exec for custom content role

PRWeek and MM&M hire NBC exec for custom content role

By

Emmy-nominated Maia Samuel becomes executive director of expanded Haymarket Content Lab; Bernadette Casey promoted to executive director of Haymarket Content Hub.

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

By

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Media is where agencies are hurting

Media is where agencies are hurting

By

Why is revenue growth at some of the agency groups lagging forecasts for global ad expenditure?

Pharma's $6 billion annual ad spend targeted by media publishers

Pharma's $6 billion annual ad spend targeted by media publishers

By

Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.

Point-of-care group rolls out guidelines

Point-of-care group rolls out guidelines

By

The goal is to further cement point of care as a mainstream media channel.

New ANA report finds 'transparency concerns' in production process

New ANA report finds 'transparency concerns' in production process

By

In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.

WebMD sells to private equity firm KKR

WebMD sells to private equity firm KKR

By

The deal is worth roughly $2.8 billion.

Five things for pharma marketers to know: Wednesday, July 5, 2017

Five things for pharma marketers to know: Wednesday, July 5, 2017

By

Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans

Roundtable: When it comes to media, pharma compares the new with the old

Roundtable: When it comes to media, pharma compares the new with the old

By

In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

By

This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.

Gilead, Astellas also suspend ads on 'The O'Reilly Factor'

Gilead, Astellas also suspend ads on 'The O'Reilly Factor'

By

Bayer, Eli Lilly, GlaxoSmithKline, and Sanofi have suspended advertising on the show, according to news reports.

Healthgrades' Eric Jensen on providing quality of life

Healthgrades' Eric Jensen on providing quality of life

By

Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.

MM&M's top 5 stories in February 2017

MM&M's top 5 stories in February 2017

By

WPP creates WPP Health & Wellness; Publicis Health formalizes new name; 10 ways healthcare companies are testing Instagram

WebMD considers sale or merger

WebMD considers sale or merger

By

Drugmakers are becoming much more cautious with their budgets, WebMD executives said.

J2 Global considers divesting parts of Everyday Health

J2 Global considers divesting parts of Everyday Health

By

The company acquired Everyday Health in December.

MM&M's top 5 stories in January 2017

MM&M's top 5 stories in January 2017

By

Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation

As users move to mobile, Google says they made 200 million queries for info about cancer drugs

As users move to mobile, Google says they made 200 million queries for info about cancer drugs

By

The search-engine giant says that one in 20 online searches are related to healthcare, and more users are using mobile to consume media.

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

Five things for pharma marketers to know: Monday, November 28, 2016

Five things for pharma marketers to know: Monday, November 28, 2016

By

J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe

Physicians still rely on medical journals but turn to the web when they have only 10 minutes

Physicians still rely on medical journals but turn to the web when they have only 10 minutes

By

Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.

Merck Consumer Health CMO on who makes healthcare decisions

Merck Consumer Health CMO on who makes healthcare decisions

By

Merck Consumer Health CMO Atilla Cansun also talks about about why the company is focused on preparing society for an average lifespan of 100 years.